Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Although antiretrovirals are the mainstay of therapy against HIV infection, neurological complications associated with the virus continue to hamper quality of life of the infected individuals. Drugs of abuse in the infected individuals further fuel the epidemic. Epidemiological studies have demonstrated that abuse of cocaine resulted in acceleration of HIV infection and the progression of NeuroAIDS. Cocaine has not only been shown to play a crucial role in promoting virus replication, but also has diverse but often deleterious effects on various cell types of the CNS. In the neuronal system, cocaine exposure results in neuronal toxicity and also potentiates gp120-induced neurotoxicity. In the astroglia and microglia, cocaine exposure leads to up-regulation of pro-inflammatory mediators such as cytokines and chemokines. These in turn, can lead to neuroinflammation and transmission of toxic responses to the neurons. Additionally, cocaine exposure can also lead to leakiness of the blood-brain barrier that manifests as enhanced transmigraiton of leukocytes/monocytes into the CNS. Both in vitro and in vivo studies have provided valuable tools in exploring the role of cocaine in mediating HIV-associated neuropathogenesis. This review summarizes previous studies on the mechanism(s) underlying the interplay of cocaine and HIV as it relates to the CNS.

[1]  V. Purohit,et al.  Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia , 2011, Molecular Neurobiology.

[2]  Honghong Yao,et al.  Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. , 2011, Blood.

[3]  Honghong Yao,et al.  Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways , 2009, Journal of NeuroVirology.

[4]  J. Becker,et al.  HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998 , 2001, Neurology.

[5]  Honghong Yao,et al.  Cocaine Potentiates Astrocyte Toxicity Mediated by Human Immunodeficiency Virus (HIV-1) Protein gp120 , 2010, PloS one.

[6]  H. Gendelman,et al.  Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. , 2010, Blood.

[7]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[8]  A. Venkatesan,et al.  Evolution of HIV dementia with HIV infection , 2008, International review of psychiatry.

[9]  J. Bell,et al.  The Neuropathology of HIV/AIDS , 2008, International review of psychiatry.

[10]  S. Lipton,et al.  The neuropathogenesis of HIV‐1 infection , 1994, Handbook of clinical neurology.

[11]  Shuxian Hu,et al.  Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. , 2006, International immunopharmacology.

[12]  A. Nath,et al.  Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. , 2006, Neurotoxicology.

[13]  R. Ellis,et al.  Human immunodeficiency virus and the central nervous system. , 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[14]  P. Simmonds,et al.  Influence of HAART on HIV-related CNS disease and neuroinflammation. , 2005, Journal of neuropathology and experimental neurology.

[15]  A. Nath,et al.  Synergistic increases in intracellular Ca2+, and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat , 2005, Glia.

[16]  A. Nath,et al.  Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV‐1 Tat exposure in vitro , 2004, The European journal of neuroscience.

[17]  Richard Graham Knowles,et al.  Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. , 2004, Neuroscience letters.

[18]  C. Newton,et al.  Microbial Infections, Immunomodulation, and Drugs of Abuse , 2003, Clinical Microbiology Reviews.

[19]  T. Rogers,et al.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. , 2003, Virology.

[20]  A. Nath,et al.  Human immunodeficiency virus‐1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function , 2002, Journal of neurochemistry.

[21]  A. Nath,et al.  Molecular Basis for Interactions of HIV and Drugs of Abuse , 2002, Journal of acquired immune deficiency syndromes.

[22]  M. Roth,et al.  Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. , 2002, The Journal of infectious diseases.

[23]  Yong Woo Lee,et al.  Cocaine activates redox-regulated transcription factors and induces TNF-α expression in human brain endothelial cells , 2001, Brain Research.

[24]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[25]  M. Mattson,et al.  Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine , 2001, BMC Neuroscience.

[26]  J. Zhang,et al.  Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro , 2001, Neuroscience.

[27]  J. Morley,et al.  Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[28]  S. Mahajan,et al.  The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. , 2000, Cellular and molecular biology.

[29]  A. Bansal,et al.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.

[30]  S. D. House,et al.  Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. , 2000, Life sciences.

[31]  Melina V Jones,et al.  Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia , 2000, Journal of psychopharmacology.

[32]  D. Vlahov,et al.  Correlates of HIV infection among young adult short-term injection drug users , 2000, AIDS.

[33]  Tomlinson,et al.  Upregulation of microglia in drug users with and without pre‐symptomatic HIV infection , 1999, Neuropathology and applied neurobiology.

[34]  M. Kaul,et al.  Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L Zhang,et al.  Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. , 1999, Clinical immunology.

[36]  M. Webber,et al.  A prospective study of HIV disease progression in female and male drug users. , 1999, AIDS.

[37]  A. Nath,et al.  Pathobiology of Human Immunodeficiency Virus Dementia , 1999, Seminars in neurology.

[38]  S. L. Chang,et al.  Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. , 1998, Clinical immunology and immunopathology.

[39]  M. Roth,et al.  Acute and chronic effects of cocaine on the immune system and the possible link to AIDS , 1998, Journal of Neuroimmunology.

[40]  T. Eisenstein,et al.  Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations , 1998, Journal of Neuroimmunology.

[41]  J. Bell,et al.  The neuropathology of adult HIV infection. , 1998, Revue neurologique.

[42]  S. D. House,et al.  Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? , 1998, Advances in experimental medicine and biology.

[43]  A. N. Park,et al.  Marijuana and cocaine impair alveolar macrophage function and cytokine production. , 1997, American journal of respiratory and critical care medicine.

[44]  M. Weinand,et al.  A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. , 1997, Journal of immunology.

[45]  P. Riederer,et al.  Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. , 1997, Journal of neurovirology.

[46]  L. Epstein,et al.  Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. , 1997, Journal of neurovirology.

[47]  D. Tashkin,et al.  Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. , 1996, Cellular immunology.

[48]  H. Gendelman,et al.  Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. , 1996, Journal of immunology.

[49]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[50]  S. Lipton,et al.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. , 1995, The New England journal of medicine.

[51]  O. Bagasra,et al.  Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. , 1993, The Journal of infectious diseases.

[52]  S. Zierler,et al.  Entangled epidemics: cocaine use and HIV disease. , 1993, Journal of psychoactive drugs.

[53]  G. Levi,et al.  Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: A study with rat cerebellar granule cell cultures , 1993, Journal of neuroscience research.

[54]  K. Matsui,et al.  Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. , 1993, International journal of immunopharmacology.

[55]  D. Vlahov,et al.  New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. , 1991, American journal of epidemiology.

[56]  M. Chiasson,et al.  Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). , 1991, AIDS.

[57]  S. Lipton,et al.  Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity , 1991, Neuron.

[58]  Herbert Budka,et al.  Neuropathology of Human Immunodeficiency Virus Infection , 1991, Brain pathology.

[59]  H. Balfour,et al.  Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. , 1990, AIDS.

[60]  R. Chaisson,et al.  Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.